Informed Consent in Clinical Trials: Before You Sign, Watch This
Have you ever signed a document without fully reading it? When it comes to clinical trials, informed consent is your most important protection, and the signature is only part of the story. The Clarity Clinical Solutions video "Informed Consent in Clinical Trials: Before You Sign, Watch This" explains what consent really means and what to look for before signing. This article covers the same material, with the regulations spelled out.
Consent is a process, not a paper
Informed consent is an ongoing conversation between you and the research team, not a one-time signature. It rests on three pillars, first defined in the Belmont Report, as the video notes. The first pillar is information: you must be told the purpose, procedures, risks, benefits, and alternatives in plain language. The second is understanding: the team must confirm you actually comprehend what you are agreeing to. The third is voluntariness: your decision must be free from coercion, and you can say no or leave at any time.
The system exists because of a dark history. The Tuskegee syphilis study, which ran from 1932 to 1972, denied hundreds of Black men treatment for syphilis without their knowledge. The Nuremberg Code of 1947 was the first international code to declare that voluntary consent is absolutely essential (The Nuremberg Code, US Holocaust Memorial Museum). The Belmont Report followed in 1979 and set out the principles that still guide human subject research.
The eight required elements
US federal regulations require eight specific elements in every consent form, listed in 21 CFR 50.25 (eCFR 21 CFR 50.25):
- The purpose and procedures of the study
- The reasonably foreseeable risks and discomforts
- The potential benefits
- The duration of the study
- The alternative treatments available instead of the trial
- How your personal data will be kept confidential
- Compensation if you are injured
- Who to contact with questions or concerns
Plus a clear statement that participation is voluntary. The FDA's guidance on informed consent adds practical detail on how sponsors and sites should meet these requirements (FDA Informed Consent Information Sheet).
Signing is just the beginning
Many people do not realize that signing the form starts the conversation rather than ending it. If new information comes up during the study, such as newly discovered side effects, you must be informed again and asked whether you want to continue. That is called reconsent. You should also never feel pressured to sign on the spot. Take the form home. Discuss it with your family and your own doctor.
Understanding is the hard part
Consent forms are supposed to be written at about an eighth-grade reading level, but even then, the research team should use the teach-back method: ask you to explain the study in your own words. Diagrams, charts, and videos can help. A useful test from the video: if you cannot explain the study to someone else, you may not understand it well enough to consent.
Voluntariness is a legal right
Your decision must be free. Your doctor cannot threaten to withhold standard medical care if you refuse to join. Payments must be reasonable, not so large that they cloud your judgment. And most importantly, you can withdraw from a trial at any time, for any reason, without penalty or loss of benefits. That is not a courtesy. It is your legal right under the regulation itself, which says participation is voluntary and you may discontinue at any time without penalty (21 CFR 50.25(a)(8)).
Risks, benefits, and vulnerable groups
Every consent form must present both sides. Risks to look for include physical side effects, discomfort from procedures, the time commitment, and the possibility of receiving a placebo. Potential benefits include early access to new treatments, closer medical monitoring, and helping future patients. The form should give you enough to weigh both.
Some groups get extra protection under federal regulations. Children need parental permission plus their own assent once they are old enough to understand. Pregnant women have specific risk-benefit rules. Prisoners face strict oversight because their environment limits free choice. Cognitively impaired adults require a legally authorized representative to consent on their behalf. These protections are written into the regulations (21 CFR Part 50, Subpart D, additional protections for children).
Common myths
The video knocks down four myths. Myth one: once I sign, I have to stay. False, you can leave anytime. Myth two: I will lose my doctor if I leave. False, you return to standard care. Myth three: it is just a form to sign. False, it is an ongoing conversation. Myth four: the form is a binding contract. False, it is an information document that protects your rights.
Questions to ask before you sign
Ask what the purpose of the study is, what exactly will happen to you, what the main risks and side effects are, whether there are potential benefits for you, what your other options are, and whether you can leave at any time and what happens then. A good research team welcomes these questions. The IRB, which reviews every consent form before a study starts, is another backstop, and its contact number is on the form.
E-consent changes the medium, not the rules
Electronic consent, or e-consent, is changing how the process works. Tablets, videos, and interactive modules can make information more engaging, and studies cited in the video show multimedia improves comprehension. It also enables remote consent, which accelerated during the COVID-19 pandemic. But e-consent must still contain all eight required elements. The FDA's guidance on electronic consent is explicit that the technology does not replace the legal requirements (FDA Guidance: Use of Electronic Informed Consent in Clinical Investigations).
The bottom line
Informed consent rests on three pillars: information, understanding, and voluntariness. You have the right to know the purpose, risks, benefits, and alternatives before you agree. You have the right to take the form home and discuss it with your family. And you have the right to leave the trial at any time, for any reason. Never sign something you do not fully understand. Ask questions, take your time, and know your rights.
This article is based on the Clarity Clinical Solutions video "Informed Consent in Clinical Trials: Before You Sign, Watch This." Watch it here: Informed Consent in Clinical Trials: Before You Sign, Watch This
References
- Clarity Clinical Solutions — "Informed Consent in Clinical Trials: Before You Sign, Watch This" (source video). https://www.youtube.com/watch?v=ZkI-UJTzBys
- eCFR — 21 CFR 50.25, Elements of Informed Consent. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-50/subpart-B/section-50.25
- eCFR — 21 CFR Part 50, Subpart D, Additional Safeguards for Children in Clinical Investigations. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-50/subpart-D
- FDA — Informed Consent Information Sheet (guidance). https://www.fda.gov/regulatory-information/search-fda-guidance-documents/informed-consent-information-sheet
- FDA — Use of Electronic Informed Consent in Clinical Investigations (guidance). https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-electronic-informed-consent-clinical-investigations-questions-and-answers
- United States Holocaust Memorial Museum — The Nuremberg Code. https://encyclopedia.ushmm.org/content/en/article/the-nuremberg-code